A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users
Status:
Recruiting
Trial end date:
2023-08-08
Target enrollment:
Participant gender:
Summary
This will be a randomized, double-blind, placebo- and active-controlled, 5-way crossover
study to evaluate the abuse potential, safety and pharmacokinetics of orally administered
PF614 relative to oxycodone IR (immediate-release) tablets and placebo.